Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jun 26, 2022 11:51am
170 Views
Post# 34783058

RE:RE:RE:RE:RE:RE:RE:RE:Bioasis Connections

RE:RE:RE:RE:RE:RE:RE:RE:Bioasis Connections
KayakerBC, as some shareholders learned by mistake at the Vancouver airport gathering, the quote you presented from the subsequent Zoom meeting contains a falsehood. Either that or a revelation made at the airport was a falsehood, but because it was revealed in a Bioasis document, by mistake, I would tend to believe the airport statement. I have a copy of that document, as the attendees and likely many others have.
 
I have written a number of posts about the issue. I won't reveal the details just yet but I do hope the company will straighten it out. There is now a considerable number of shareholders who do not believe the quote you posted. (There may be something new about xB3-001 in the Q1 filings at the end of July.)
 
And as of this moment the corporate presentation has still not been updated because doing so would likely require the revelation of the actual status of xB3-001 and maybe other things that the company doesn't want revealed yet. That's why I called it "tactical procrastination" or something like that.
 
I understand the dilemma the company is in. Regardless, they need to handle it with proper disclosure. And the thing is, it appears to be really good news.

It seems to me that the company is far too willing to keep things secret at the request of partners. It creates concern about the ability Bioasis has to effectively negotiate with partners, concerns that add to those caused by the poorly-valued deals that Bioasis has so far entered.
 
jd
<< Previous
Bullboard Posts
Next >>